Companies: 10,795·Total market cap: $144.5T
Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL.VTSXVHealthcare● Active
$0.24
+$0.05(+23.08%)
Market Cap$15126790
P/E Ratio
52W High$0.4
52W Low$0.09
Overview

Marvel Biosciences Corp. (MRVL.V) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MRVL.V · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.04mrvl.v eps ttm · mrvl.v earnings per shareEarnings history
PE Ratio (TTM)mrvl.v pe ratio ttm · mrvl.v price to earningsPE Ratio deep dive
Revenue (TTM)0.00mrvl.v revenue ttm · mrvl.v annual revenueFull revenue history
Dividend YieldNo Dividenddoes mrvl.v pay dividends · mrvl.v dividend yieldDividend history
Shares Outstanding47.3Mmrvl.v shares outstanding · mrvl.v floatShares outstanding history
Next EarningsJun 17, 2026Est.mrvl.v earnings date · mrvl.v next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
marvel biosciences corp. revenue · mrvl.v revenue 2025
FY 2025Net Income-$2.2M▼ 133928.36% YoY
202320242025
marvel biosciences corp. net income · mrvl.v profit 2025
FY 2025EPS$-0.05▲ +99.89% YoY
202320242025
mrvl.v eps · marvel biosciences corp. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$2.1MEPS: $-0.04View income statement →

Stock Performance

Full History
1D+23.08%
1W+45.45%
1M+60.00%
3M+71.43%
YTD+77.78%
1Y+140.00%
5Y-38.46%

About Marvel Biosciences Corp.

CEOJ. Roderick Matheson
IPO DateJul 13, 2021
Employees5
CountryCA

Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs…

what is marvel biosciences corp. · mrvl.v stock overview · marvel biosciences corp. company profile · who is marvel biosciences corp. ceo · mrvl.v TSXV · marvel biosciences corp. headquarters · marvel biosciences corp. business segments

About Stock Overview & Key Data

Marvel Biosciences Corp. (MRVL.V) is a Healthcare company in the Biotechnology industry, listed on TSXV since Jul 13, 2021. As of the latest trading session, MRVL.V stock price is $0.24, with a market capitalization of $15.1M. The stock has returned +140.00% over the past 12 months and +77.78% year-to-date.

In fiscal year 2025, Marvel Biosciences Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Marvel Biosciences Corp. (MRVL.V) stock price is $0.24. The stock is traded on TSXV under the ticker symbol MRVL.V. The 52-week range is $0.09 – $0.40.

MRVL.V stock priceMRVL.V quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice